Annual Operating Profit
-$116.22 M
-$96.43 M-487.11%
December 31, 2023
Summary
- As of February 7, 2025, RPTX annual operating income is -$116.22 million, with the most recent change of -$96.43 million (-487.11%) on December 31, 2023.
- During the last 3 years, RPTX annual operating profit has fallen by -$61.92 million (-114.03%).
- RPTX annual operating profit is now -1782.17% below its all-time high of -$6.17 million, reached on December 31, 2017.
Performance
RPTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$34.84 M
+$2.47 M+6.63%
September 30, 2024
Summary
- As of February 7, 2025, RPTX quarterly operating income is -$34.84 million, with the most recent change of +$2.47 million (+6.63%) on September 30, 2024.
- Over the past year, RPTX quarterly operating profit has increased by +$3.57 million (+9.30%).
- RPTX quarterly operating profit is now -147.47% below its all-time high of $73.40 million, reached on September 30, 2022.
Performance
RPTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$92.22 M
+$3.57 M+3.73%
September 30, 2024
Summary
- As of February 7, 2025, RPTX TTM operating income is -$92.22 million, with the most recent change of +$3.57 million (+3.73%) on September 30, 2024.
- Over the past year, RPTX TTM operating profit has increased by +$12.77 million (+12.17%).
- RPTX TTM operating profit is now -1450.54% below its all-time high of $6.83 million, reached on June 30, 2023.
Performance
RPTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RPTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -487.1% | +9.3% | +12.2% |
| 3 y3 years | -114.0% | -10.0% | +4.9% |
| 5 y5 years | -806.6% | -407.4% | -249.6% |
RPTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -487.1% | at low | -147.5% | +10.0% | -1450.5% | +31.2% |
| 5 y | 5-year | -487.1% | at low | -147.5% | +10.0% | -1450.5% | +31.2% |
| alltime | all time | -1782.2% | at low | -147.5% | +10.0% | -1450.5% | +31.2% |
Repare Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$34.84 M(-6.6%) | -$92.22 M(-3.7%) |
| Jun 2024 | - | -$37.32 M(-445.0%) | -$95.79 M(+35.4%) |
| Mar 2024 | - | $10.82 M(-135.0%) | -$70.73 M(-39.1%) |
| Dec 2023 | -$116.22 M(+487.1%) | -$30.87 M(-19.7%) | -$116.22 M(+10.7%) |
| Sep 2023 | - | -$38.42 M(+213.4%) | -$104.99 M(-1637.6%) |
| Jun 2023 | - | -$12.26 M(-64.7%) | $6.83 M(-134.8%) |
| Mar 2023 | - | -$34.68 M(+76.7%) | -$19.65 M(-0.7%) |
| Dec 2022 | -$19.80 M(-81.8%) | -$19.63 M(-126.7%) | -$19.80 M(-31.5%) |
| Sep 2022 | - | $73.40 M(-289.5%) | -$28.90 M(-78.4%) |
| Jun 2022 | - | -$38.73 M(+11.2%) | -$133.98 M(+9.9%) |
| Mar 2022 | - | -$34.83 M(+21.2%) | -$121.91 M(+12.2%) |
| Dec 2021 | -$108.66 M | -$28.73 M(-9.3%) | -$108.66 M(+12.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$31.68 M(+18.8%) | -$97.00 M(+22.2%) |
| Jun 2021 | - | -$26.67 M(+23.6%) | -$79.41 M(+22.0%) |
| Mar 2021 | - | -$21.58 M(+26.4%) | -$65.07 M(+19.8%) |
| Dec 2020 | -$54.30 M(+105.9%) | -$17.08 M(+21.2%) | -$54.30 M(+17.9%) |
| Sep 2020 | - | -$14.09 M(+14.3%) | -$46.07 M(+18.6%) |
| Jun 2020 | - | -$12.32 M(+13.9%) | -$38.85 M(+19.9%) |
| Mar 2020 | - | -$10.81 M(+22.3%) | -$32.41 M(+22.9%) |
| Dec 2019 | -$26.38 M(+105.7%) | -$8.85 M(+28.8%) | -$26.38 M(+50.5%) |
| Sep 2019 | - | -$6.87 M(+16.7%) | -$17.53 M(+64.4%) |
| Jun 2019 | - | -$5.88 M(+23.1%) | -$10.66 M(+123.1%) |
| Mar 2019 | - | -$4.78 M | -$4.78 M |
| Dec 2018 | -$12.82 M(+107.6%) | - | - |
| Dec 2017 | -$6.17 M | - | - |
FAQ
- What is Repare Therapeutics annual operating income?
- What is the all time high annual operating profit for Repare Therapeutics?
- What is Repare Therapeutics annual operating profit year-on-year change?
- What is Repare Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Repare Therapeutics?
- What is Repare Therapeutics quarterly operating profit year-on-year change?
- What is Repare Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Repare Therapeutics?
- What is Repare Therapeutics TTM operating profit year-on-year change?
What is Repare Therapeutics annual operating income?
The current annual operating profit of RPTX is -$116.22 M
What is the all time high annual operating profit for Repare Therapeutics?
Repare Therapeutics all-time high annual operating income is -$6.17 M
What is Repare Therapeutics annual operating profit year-on-year change?
Over the past year, RPTX annual operating income has changed by -$96.43 M (-487.11%)
What is Repare Therapeutics quarterly operating income?
The current quarterly operating profit of RPTX is -$34.84 M
What is the all time high quarterly operating profit for Repare Therapeutics?
Repare Therapeutics all-time high quarterly operating income is $73.40 M
What is Repare Therapeutics quarterly operating profit year-on-year change?
Over the past year, RPTX quarterly operating income has changed by +$3.57 M (+9.30%)
What is Repare Therapeutics TTM operating income?
The current TTM operating profit of RPTX is -$92.22 M
What is the all time high TTM operating profit for Repare Therapeutics?
Repare Therapeutics all-time high TTM operating income is $6.83 M
What is Repare Therapeutics TTM operating profit year-on-year change?
Over the past year, RPTX TTM operating income has changed by +$12.77 M (+12.17%)